{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:08:29Z","timestamp":1774897709346,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang Province Medical and Health Science and Technology Project","award":["2025KY281"],"award-info":[{"award-number":["2025KY281"]}]},{"name":"Zhejiang Science and Technology Plan for Disease Prevention and Control","award":["2025JK072"],"award-info":[{"award-number":["2025JK072"]}]},{"name":"Ningbo Top Medical and Health Research Program","award":["2023020713"],"award-info":[{"award-number":["2023020713"]}]},{"DOI":"10.13039\/501100010248","name":"Zhejiang Province Public Welfare Technology Application Research Project","doi-asserted-by":"publisher","award":["LGF22H260020"],"award-info":[{"award-number":["LGF22H260020"]}],"id":[{"id":"10.13039\/501100010248","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Welfare Science and Technology Project of Ningbo City","award":["2022S071"],"award-info":[{"award-number":["2022S071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Stroke is a leading cause of disability and mortality among older adults, with high recurrence rates. Currently, there\u2019s limited research reporting on the protective effect of influenza vaccination against recurrent stroke in elderly stroke survivors. This study aimed to evaluate the association between influenza vaccination and stroke risk in this group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted using data from the Ningbo Regional Health Information Platform. Eligible participants were adults aged\u2009\u2265\u200965 years with a history of stroke, registered in the platform for \u2265\u20091 year by December 31, 2021. Follow-up ended at stroke occurrence, death, or July 31, 2022, whichever occurred first. The primary outcome was any stroke event. Exposure was defined as influenza vaccination during the 2021\u20132022 season. Adjusted subdistribution hazard ratios (sHRs) and 95% confidence intervals (CIs) were estimated using Fine-Gray competing risk models. Pneumococcal vaccination was included as a negative control outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 76,747 participants, 31,729 (41.3%) received influenza vaccination. Over 7 months, 6,323 stroke events occurred: 5,631 ischemic, 653 hemorrhagic, and 39 unspecified. After adjusting for demographics and comorbidities, influenza vaccination was associated with a reduced risk of ischemic stroke among elderly stroke survivors (particularly those whose last stroke event occurred\u2009\u2265\u20091 year prior) (adjusted sHR: 0.90, 95% CI: 0.85\u20130.95) but showed no significant association with hemorrhagic stroke risk (adjusted sHR: 0.89, 95% CI: 0.76\u20131.05). Additionally, influenza vaccination demonstrated significant protective effects against both cardiogenic stroke (adjusted sHR: 0.74, 95% CI: 0.63\u20130.86) and non-cardiogenic stroke (adjusted sHR: 0.93, 95% CI: 0.88\u20130.98), with a stronger protective effect observed for cardiogenic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Influenza vaccination is associated with lower ischemic stroke risk among elderly stroke survivors, independent of cardiogenic etiology. These findings suggest a potential nonspecific preventive benefit and highlight the need for randomized trials to establish causality and inform clinical guidelines for stroke survivors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-025-06695-x","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:46:52Z","timestamp":1764334012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Influenza vaccination and ischemic stroke risk reduction in elderly stroke survivors: a retrospective cohort study with negative control validation"],"prefix":"10.1186","volume":"25","author":[{"given":"Tianchi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"6695_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and National burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20:795\u2013820. https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0.","journal-title":"Lancet Neurol"},{"key":"6695_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0038-1649503","volume":"38","author":"M Katan","year":"2018","unstructured":"Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38:208\u201311. https:\/\/doi.org\/10.1055\/s-0038-1649503.","journal-title":"Semin Neurol"},{"key":"6695_CR3","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/STROKEAHA.120.028992","volume":"51","author":"C Flach","year":"2020","unstructured":"Flach C, Muruet W, Wolfe CDA, Bhalla A, Douiri A. Risk and secondary prevention of stroke recurrence: A Population-Base cohort study. Stroke. 2020;51:2435\u201344. https:\/\/doi.org\/10.1161\/STROKEAHA.120.028992.","journal-title":"Stroke"},{"key":"6695_CR4","doi-asserted-by":"publisher","first-page":"e2219698","DOI":"10.1001\/jamanetworkopen.2022.19698","volume":"5","author":"C Mao","year":"2022","unstructured":"Mao C, Li M. Stroke recurrence as a challenge for countries. JAMA Netw Open. 2022;5:e2219698. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.19698.","journal-title":"JAMA Netw Open"},{"key":"6695_CR5","doi-asserted-by":"publisher","first-page":"1324677","DOI":"10.3389\/fneur.2023.1324677","volume":"14","author":"JA Zahhar","year":"2023","unstructured":"Zahhar JA, Salamatullah HK, Almutairi MB, Faidah DE, Afif LM, Banjar TA, et al. Influenza vaccine effect on risk of stroke occurrence: a systematic review and meta-analysis. Front Neurol. 2023;14:1324677. https:\/\/doi.org\/10.3389\/fneur.2023.1324677.","journal-title":"Front Neurol"},{"key":"6695_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2018.01.007","volume":"386","author":"G Tsivgoulis","year":"2018","unstructured":"Tsivgoulis G, Katsanos AH, Zand R, Ishfaq MF, Malik MT, Karapanayiotides T, et al. The association of adult vaccination with the risk of cerebrovascular ischemia: A systematic review and meta-analysis. J Neurol Sci. 2018;386:12\u20138. https:\/\/doi.org\/10.1016\/j.jns.2018.01.007.","journal-title":"J Neurol Sci"},{"key":"6695_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000478017","volume":"48","author":"KR Lee","year":"2017","unstructured":"Lee KR, Bae JH, Hwang IC, Kim KK, Suh HS, Ko KD. Effect of influenza vaccination on risk of stroke: A systematic review and Meta-Analysis. Neuroepidemiology. 2017;48:103\u201310. https:\/\/doi.org\/10.1159\/000478017.","journal-title":"Neuroepidemiology"},{"key":"6695_CR8","doi-asserted-by":"publisher","first-page":"e16239","DOI":"10.1111\/ene.16239","volume":"31","author":"MSV Elkind","year":"2024","unstructured":"Elkind MSV, de Abajo FJ. Benefits of influenza vaccine on stroke beyond preventing infection: paradigm change or sheer bias? Eur J Neurol. 2024;31:e16239. https:\/\/doi.org\/10.1111\/ene.16239.","journal-title":"Eur J Neurol"},{"key":"6695_CR9","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1212\/WNL.0000000000000456","volume":"82","author":"PC Lavall\u00e9e","year":"2014","unstructured":"Lavall\u00e9e PC, Labreuche J, Fox KM, Lavados P, Mattle H, Steg PG, et al. Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke. Neurology. 2014;82:1905\u201313. https:\/\/doi.org\/10.1212\/WNL.0000000000000456.","journal-title":"Neurology"},{"key":"6695_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.vaccine.2017.12.019","volume":"36","author":"P Jorgensen","year":"2018","unstructured":"Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C. How close are countries of the WHO European region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from National surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015. Vaccine. 2018;36:442\u201352. https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.019.","journal-title":"Vaccine"},{"key":"6695_CR11","doi-asserted-by":"publisher","first-page":"125986","DOI":"10.1016\/j.vaccine.2024.05.034","volume":"42","author":"T Yang","year":"2024","unstructured":"Yang T, Tong F, Tang L, Li P, Li B, Ye L, et al. Repeated vaccination does not appear to significantly weaken the protective effect of influenza vaccine in the elderly: A test-negative case-control study in China. Vaccine. 2024;42:125986. https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.034.","journal-title":"Vaccine"},{"key":"6695_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12877-024-05003-3","volume":"24","author":"T Yang","year":"2024","unstructured":"Yang T, Tang L, Li P, Li B, Ye L, Zhou J. Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design. BMC Geriatr. 2024;24:404. https:\/\/doi.org\/10.1186\/s12877-024-05003-3.","journal-title":"BMC Geriatr"},{"key":"6695_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/14760584.2023.2239911","volume":"22","author":"R Meng","year":"2023","unstructured":"Meng R, Ma R, Wang J, Liu P, Liu Z, He B, et al. Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China. Expert Rev Vaccines. 2023;22:696\u2013703. https:\/\/doi.org\/10.1080\/14760584.2023.2239911.","journal-title":"Expert Rev Vaccines"},{"key":"6695_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/infdis\/jix632","volume":"217","author":"B Young","year":"2018","unstructured":"Young B, Sadarangani S, Jiang L, Wilder-Smith A, Chen MI-C. Duration of influenza vaccine effectiveness: A systematic Review, Meta-analysis, and Meta-regression of Test-Negative design Case-Control studies. J Infect Dis. 2018;217:731\u201341. https:\/\/doi.org\/10.1093\/infdis\/jix632.","journal-title":"J Infect Dis"},{"key":"6695_CR15","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/vaccines10060888","volume":"10","author":"W Hu","year":"2022","unstructured":"Hu W, Sjoberg PA, Fries AC, DeMarcus LS, Robbins AS. Waning vaccine protection against influenza among department of defense adult beneficiaries in the united States, 2016\u20132017 through 2019\u20132020 influenza seasons. Vaccines (Basel). 2022;10:888. https:\/\/doi.org\/10.3390\/vaccines10060888.","journal-title":"Vaccines (Basel)"},{"key":"6695_CR16","doi-asserted-by":"publisher","first-page":"e914","DOI":"10.1016\/S2468-2667(22)00222-5","volume":"7","author":"JK Holodinsky","year":"2022","unstructured":"Holodinsky JK, Zerna C, Malo S, Svenson LW, Hill MD. Association between influenza vaccination and risk of stroke in Alberta, canada: a population-based study. Lancet Public Health. 2022;7:e914\u201322. https:\/\/doi.org\/10.1016\/S2468-2667(22)00222-5.","journal-title":"Lancet Public Health"},{"key":"6695_CR17","doi-asserted-by":"publisher","first-page":"165260","DOI":"10.1016\/j.bbadis.2018.09.012","volume":"1866","author":"D Barthels","year":"2020","unstructured":"Barthels D, Das H. Current advances in ischemic stroke research and therapies. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165260. https:\/\/doi.org\/10.1016\/j.bbadis.2018.09.012.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"6695_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.amjmed.2023.02.004","volume":"136","author":"LMDS Barbetta","year":"2023","unstructured":"Barbetta LMDS, Correia ET, de Gismondi O, Mesquita RAOC. Influenza vaccination as prevention therapy for stable coronary artery disease and acute coronary syndrome: A Meta-Analysis of randomized trials. Am J Med. 2023;136:466\u201375. https:\/\/doi.org\/10.1016\/j.amjmed.2023.02.004.","journal-title":"Am J Med"},{"key":"6695_CR19","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","volume":"144","author":"O Fr\u00f6bert","year":"2021","unstructured":"Fr\u00f6bert O, G\u00f6tberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, et al. Influenza vaccination after myocardial infarction: A Randomized, Double-Blind, Placebo-Controlled, multicenter trial. Circulation. 2021;144:1476\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057042.","journal-title":"Circulation"},{"key":"6695_CR20","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1016\/S2214-109X(22)00432-6","volume":"10","author":"M Loeb","year":"2022","unstructured":"Loeb M, Roy A, Dokainish H, Dans A, Palileo-Villanueva LM, Karaye K, et al. Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2022;10:e1835\u201344. https:\/\/doi.org\/10.1016\/S2214-109X(22)00432-6.","journal-title":"Lancet Glob Health"},{"key":"6695_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1212\/WNL.0000000000201265","volume":"99","author":"D Yang","year":"2022","unstructured":"Yang D, Elkind MSV. Influenza vaccination and ischemic stroke prevention: two for the price of one. Neurology. 2022;99:827\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000201265.","journal-title":"Neurology"},{"key":"6695_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/STROKEAHA.110.596783","volume":"42","author":"S Muhammad","year":"2011","unstructured":"Muhammad S, Haasbach E, Kotchourko M, Strigli A, Krenz A, Ridder DA, et al. Influenza virus infection aggravates stroke outcome. Stroke. 2011;42:783\u201391. https:\/\/doi.org\/10.1161\/STROKEAHA.110.596783.","journal-title":"Stroke"},{"key":"6695_CR23","doi-asserted-by":"publisher","first-page":"e2149","DOI":"10.1212\/WNL.0000000000201123","volume":"99","author":"S Rodr\u00edguez-Mart\u00edn","year":"2022","unstructured":"Rodr\u00edguez-Mart\u00edn S, Barreira-Hern\u00e1ndez D, Gil M, Garc\u00eda-Lled\u00f3 A, Izquierdo-Esteban L, De Abajo F. Influenza vaccination and risk of ischemic stroke: A Population-Based Case-Control study. Neurology. 2022;99:e2149\u201360. https:\/\/doi.org\/10.1212\/WNL.0000000000201123.","journal-title":"Neurology"},{"key":"6695_CR24","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.vaccine.2014.01.029","volume":"32","author":"AN Siriwardena","year":"2014","unstructured":"Siriwardena AN, Asghar Z, Coupland CCA. Influenza and Pneumococcal vaccination and risk of stroke or transient ischaemic attack-matched case control study. Vaccine. 2014;32:1354\u201361. https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.029.","journal-title":"Vaccine"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06695-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06695-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06695-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:46:52Z","timestamp":1764334012000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-06695-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6695"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06695-x","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Ethics Committee of Ningbo Municipal Center for Disease Control and Prevention, China (IRB. No: 202208). The need for Informed Consent was waived by the Ethics Committee of Ningbo Municipal Center for Disease Control and Prevention, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that there are no reported conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"984"}}